These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19805013)

  • 1. A survey of treatment practices in diabetic peripheral neuropathy.
    Possidente CJ; Tandan R
    Prim Care Diabetes; 2009 Nov; 3(4):253-7. PubMed ID: 19805013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
    Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
    Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients.
    Erbas T; Ertas M; Yucel A; Keskinaslan A; Senocak M;
    J Clin Neurophysiol; 2011 Feb; 28(1):51-5. PubMed ID: 21221008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns.
    Tölle T; Xu X; Sadosky AB
    J Diabetes Complications; 2006; 20(1):26-33. PubMed ID: 16389164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.
    Gore M; Brandenburg NA; Hoffman DL; Tai KS; Stacey B
    J Pain; 2006 Dec; 7(12):892-900. PubMed ID: 17157775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy.
    Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
    J Vasc Nurs; 2005 Sep; 23(3):97-104. PubMed ID: 16125633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
    Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
    J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
    Zelman DC; Gore M; Dukes E; Tai KS; Brandenburg N
    J Pain Symptom Manage; 2005 Apr; 29(4):401-10. PubMed ID: 15857744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
    Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
    Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful neuropathies.
    Sommer C
    Curr Opin Neurol; 2003 Oct; 16(5):623-8. PubMed ID: 14501847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic peripheral neuropathy and the management of diabetic peripheral neuropathic pain.
    Morales-Vidal S; Morgan C; McCoyd M; Hornik A
    Postgrad Med; 2012 Jul; 124(4):145-53. PubMed ID: 22913903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of illness in painful diabetic peripheral neuropathy.
    Giannopoulos S; Pelidou SH; Kyritsis AP; Kosmidou M
    J Pain; 2007 Jun; 8(6):530. PubMed ID: 17481958
    [No Abstract]   [Full Text] [Related]  

  • 13. Conservative treatment of peripheral neuropathy and neuropathic pain.
    Francis DA; Christopher AT; Beasley BD
    Clin Podiatr Med Surg; 2006 Jul; 23(3):509-30. PubMed ID: 16958385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy.
    Ertas M; Sagduyu A; Arac N; Uludag B; Ertekin C
    Pain; 1998 Apr; 75(2-3):257-9. PubMed ID: 9583761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental models of painful diabetic neuropathy.
    Calcutt NA
    J Neurol Sci; 2004 May; 220(1-2):137-9. PubMed ID: 15140623
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pain and treatment satisfaction in patients with painful diabetic peripheral neuropathy.
    Dulipsingh L; Zailskas S; Goldsby T; McInnis T; Marotta A
    Conn Med; 2013 Oct; 77(9):523-7. PubMed ID: 24266128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy.
    Cohen KL; Harris S
    Arch Intern Med; 1987 Aug; 147(8):1442-4. PubMed ID: 3115210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Examination of questionnaires regarding diabetic peripheral neuropathy in epalrestat-treated patients and their usefulness in the treatment of the patients during the treatment course].
    Ito A; Ishii-Nozawa R; Ibuki C; Atarashi H; Kataoka H; Takeuchi K
    Yakugaku Zasshi; 2009 Oct; 129(10):1239-47. PubMed ID: 19797880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.